Loading clinical trials...
Loading clinical trials...
Comparison of Ciclesonide (80 mcg or 160 mcg Once Daily in the Evening) and Fluticasone Propionate (100 mcg Twice Daily in the Morning and Evening) in Pediatric Asthma Patients
Conditions
Interventions
Ciclesonide
Locations
57
Brazil
Altana Pharma/Nycomed
Campinas - SP, Brazil
Altana Pharma/Nycomed
Curitiba-PR, Brazil
Altana Pharma/Nycomed
Florianópolis-SC, Brazil
Altana Pharma/Nycomed
Porto Alegre-RS, Brazil
Altana Pharma/Nycomed
Porto Alegre-RS, Brazil
Altana Pharma/Nycomed
Rio de Janeiro-RJ, Brazil
Start Date
October 1, 2004
Primary Completion Date
November 1, 2005
Completion Date
November 1, 2005
Last Updated
December 5, 2016
NCT07486401
NCT02327897
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions